Challenges of Differential Diagnosis, Symptoms of Coronavirus Disease 2019 (COVID-19) or Cannabinoid Hyperemesis Syndrome (CHS)? A Rare Case Report
,
Abstract
Coronavirus Disease 2019 (COVID-19) has become a pandemic since Mar 2020. Iran has been one of the first countries dealing with the outbreak of COVID-19 and severe measures have been adopted to limit viral transmission. Cannabinoid hyperemesis syndrome (CHS) is a syndrome of cyclic vomiting associated with cannabis use. Many of the clinical symptoms of COVID-19 are similar to CHS. Here, we report a 26-year-old man with CHS, that the presented symptoms are similar to COVID-19 in many cases, and in our knowledge, it is the first in this type. Paying attention to the symptoms can help to differential diagnosis of the two diseases and reduce the burden of treatment during this critical period.
1. Cao W (2020). Clinical features and labora-tory inspection of novel coronavirus pneumonia (COVID-19) in Xiangyang, Hubei. MioRxiv, https://doi.org/10.1101/2020.02.23.20026963.
2. Takian A, Raoofi A, Kazempour-Ardebili S (2020). COVID-19 battle during the toughest sanctions against Iran. Lancet, 395(10229):1035–6.
3. Livingston E, Bucher K (2020). Coronavirus Disease 2019 (COVID-19) in Italy. JA-MA, doi: 10.1001/jama.2020.4344.
4. Wong SH, Lui RN, Sung JJ (2020). Covid-19 and the Digestive System. J Gastroenterol Hepatol, doi: 10.1111/jgh.15047.
5. Davis W, Frye K, Shah D, Cagande C (2020). Cannabinoid Hyperemesis Syn-drome Presenting With Spontaneous Pneumomediastinum. Prim Care Companion CNS Disord, 22(2): 19l02509.
6. Pan L, Mu M, Ren HG et al (2020). Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol, doi: 10.14309/ajg.0000000000000620.
2. Takian A, Raoofi A, Kazempour-Ardebili S (2020). COVID-19 battle during the toughest sanctions against Iran. Lancet, 395(10229):1035–6.
3. Livingston E, Bucher K (2020). Coronavirus Disease 2019 (COVID-19) in Italy. JA-MA, doi: 10.1001/jama.2020.4344.
4. Wong SH, Lui RN, Sung JJ (2020). Covid-19 and the Digestive System. J Gastroenterol Hepatol, doi: 10.1111/jgh.15047.
5. Davis W, Frye K, Shah D, Cagande C (2020). Cannabinoid Hyperemesis Syn-drome Presenting With Spontaneous Pneumomediastinum. Prim Care Companion CNS Disord, 22(2): 19l02509.
6. Pan L, Mu M, Ren HG et al (2020). Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol, doi: 10.14309/ajg.0000000000000620.
| Files | ||
| Issue | Vol 49 No Supple 1 (2020) | |
| Section | Case Report(s) | |
| DOI | https://doi.org/10.18502/ijph.v49iS1.3677 | |
| Keywords | ||
| COVID-19; Cannabinoid hyperemesis syndrome (CHS); Cannabis use | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
PIRNIA B, PIRNIA K, MALEKANMEHR P, ZAHIRODDIN A. Challenges of Differential Diagnosis, Symptoms of Coronavirus Disease 2019 (COVID-19) or Cannabinoid Hyperemesis Syndrome (CHS)? A Rare Case Report. Iran J Public Health. 2020;49(Supple 1):109-111.
